These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24843710)

  • 1. Effects of insulin changes on quality of life and glycemic control in Japanese patients with type 2 diabetes mellitus: The insulin-changing study intending to gain patients' insights into insulin treatment with patient-reported health outcomes in actual clinical treatments (INSIGHTs) study.
    Ishii H; Terauchi Y; Jinnouchi H; Taketsuna M; Takeuchi M; Imaoka T
    J Diabetes Investig; 2013 Nov; 4(6):560-70. PubMed ID: 24843710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of switching basal insulin regimen to degludec on quality of life in Japanese patients with type 1 and type 2 diabetes mellitus.
    Okada M; Okada M; Nishigami J; Yamaaki N; Furukawa K; Ohyama K; Shimada T; Sai Y
    J Pharm Health Care Sci; 2015; 1():26. PubMed ID: 26819737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of quality of life through glycemic control by liraglutide, a GLP-1 analog, in insulin-naive patients with type 2 diabetes mellitus: the PAGE1 study.
    Ishii H; Niiya T; Ono Y; Inaba N; Jinnouchi H; Watada H
    Diabetol Metab Syndr; 2017; 9():3. PubMed ID: 28074109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Quality of Life and Other Patient-Reported Outcomes in the PANORAMA Multinational Study of People With Type 2 Diabetes.
    Bradley C; Eschwège E; de Pablos-Velasco P; Parhofer KG; Simon D; Vandenberghe H; Gönder-Frederick L
    Diabetes Care; 2018 Feb; 41(2):267-276. PubMed ID: 29183910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized Multicenter Evaluation of Quality of Life and Treatment Satisfaction in Type 2 Diabetes Patients Receiving Once-Weekly Trelagliptin Versus a Daily Dipeptidyl Peptidase-4 Inhibitor.
    Ishii H; Suzaki Y; Miyata Y; Matsui S
    Diabetes Ther; 2019 Aug; 10(4):1369-1380. PubMed ID: 31214997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life as a key indicator of patient satisfaction and treatment compliance in people with type 2 diabetes mellitus in the IMPROVE study: a multicentre, open label, non-randomised, observational trial.
    Mukherjee AK; Reddy VS; Shah S; Jhingan AK; Ramakrishnan P; Prusty V; Singh NS
    J Indian Med Assoc; 2009 Jul; 107(7):464-70. PubMed ID: 20112854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Patient-Led and Physician-Led Insulin Titration in Japanese Type 2 Diabetes Mellitus Patients Based on Treatment Distress, Satisfaction, and Self-Efficacy: The COMMIT-Patient Study.
    Ishii H; Nakajima H; Kamei N; Uchida D; Suzuki D; Ono Y; Sato Y; Shimono D
    Diabetes Ther; 2021 Feb; 12(2):595-611. PubMed ID: 33460017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Satisfaction and efficacy of switching from daily dipeptidyl peptidase-4 inhibitors to weekly trelagliptin in patients with type 2 diabetes-Randomized controlled study.
    Oita M; Miyoshi H; Ono K; Nakamura A; Cho KY; Nomoto H; Yamamoto K; Omori K; Manda N; Kurihara Y; Aoki S; Atsumi T
    Endocr J; 2018 Feb; 65(2):141-150. PubMed ID: 29093280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of replacing metformin with pioglitazone on glycemic control in japanese patients with poorly controlled type 2 diabetes mellitus: A 12-week, open-label, prospective study.
    Sakaue S; Kamigaki M; Yoshimura H; Nishimura M
    Curr Ther Res Clin Exp; 2008 Aug; 69(4):364-77. PubMed ID: 24692813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the Omnipod
    Polonsky WH; Hessler D; Layne JE; Zisser H
    Diabetes Technol Ther; 2016 Oct; 18(10):664-670. PubMed ID: 27673352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study Protocol for the Initial Choice of DPP-4 Inhibitor in Japanese Patients with Type 2 diabetes Mellitus: Effect of Linagliptin on QOL (INTEL-QOL) Trial.
    Mita T; Hiyoshi T; Yoshii H; Chimori H; Ikeda K; Sato J; Watada H
    Diabetes Ther; 2018 Jun; 9(3):1403-1412. PubMed ID: 29744822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient reported outcomes in adults with type 2 diabetes on basal insulin randomized to addition of mealtime pramlintide or rapid-acting insulin analogs.
    Peyrot M; Rubin RR; Polonsky WH; Best JH
    Curr Med Res Opin; 2010 May; 26(5):1047-54. PubMed ID: 20199136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis.
    Ascher-Svanum H; Zagar A; Jiang D; Schuster D; Schmitt H; Dennehy EB; Kendall DM; Raskin J; Heine RJ
    Diabetes Ther; 2015 Sep; 6(3):303-16. PubMed ID: 26159935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of Structured Self-Monitoring of Blood Glucose to the Glycemic Control and the Quality of Life in Both Insulin- and Noninsulin-Treated Patients with Poorly Controlled Diabetes.
    Kan K; Zhu W; Lu F; Shen Y; Gao F; Mo Y; He X; Bao Y; Zhou J; Jia W
    Diabetes Technol Ther; 2017 Dec; 19(12):707-714. PubMed ID: 29099626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-reported outcomes from a 16-week open-label, multicenter study of insulin pump therapy in patients with type 2 diabetes mellitus.
    Rubin RR; Peyrot M; Chen X; Frias JP
    Diabetes Technol Ther; 2010 Nov; 12(11):901-6. PubMed ID: 20879963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.
    Winkley K; Upsher R; Stahl D; Pollard D; Kasera A; Brennan A; Heller S; Ismail K
    Health Technol Assess; 2020 Jun; 24(28):1-232. PubMed ID: 32568666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Influence of Sitagliptin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Prespecified Sub-Analysis.
    Mita T; Katakami N; Shiraiwa T; Yoshii H; Gosho M; Ishii H; Shimomura I; Watada H;
    Diabetes Ther; 2017 Jun; 8(3):693-704. PubMed ID: 28516377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes treatment-related quality of life is associated with levels of self-care activities in insulin injection among Japanese patients with type 2 diabetes: Diabetes Distress and Care Registry at Tenri (DDCRT 8).
    Mashitani T; Hayashino Y; Okamura S; Kitatani M; Furuya M; Iburi T; Kuwata H; Tsujii S; Ishii H
    Acta Diabetol; 2015 Aug; 52(4):639-47. PubMed ID: 25854196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
    Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
    Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.